Trial tests vaginal lactoferrin instead of medicines for BV or thrush
Part of Infections, Women’s health & pregnancy clinical trials.
This study checks whether using lactoferrin vaginal pessaries can work for bacterial vaginosis (BV) or thrush, compared with standard antibiotic or antifungal tablets. It’s a feasibility study, meaning the main goal is to see if the approach and home sample collection are practical.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 16 and 49 years old and able to consent
- Have periods and a lab-confirmed diagnosis of BV or thrush from a swab (Gram stain)
- Be willing to be randomly assigned to either lactoferrin pessaries or standard tablets
- Agree to collect vaginal samples at home and return them to the study team
- Avoid douching during the study (don’t rinse inside the vagina)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.
This early study tests whether placing a lactic acid gel inside the vagina can change the vaginal “microbiome,” the mix of germs, to help reduce repeat BV or yeast infections. You may join if you’ve had at least two recent episodes that needed treatment.
This trial compares different ways to treat bacterial vaginosis (a common vaginal infection) in women who are not pregnant and are between 18 and 45 years old. The goal is to find which treatment works best and is easiest to follow.
This trial tests a vaginal ovule (a small insert) medical device to treat bacterial vaginosis and yeast infections. It aims to see if the device is safe and effective at relieving symptoms like discharge, itching, and burning.
This study tests whether adding probiotics to standard care helps treat bacterial vaginosis (BV) and possibly lowers the chance of it coming back. You would be placed into a study group to compare probiotic treatment with the other approach.
This trial tests a combination of BPR-101 capsules (a probiotic) and an antibiotic (metronidazole) for women with bacterial vaginosis (BV). The goal is to see if this combination is more effective and safe than standard treatment alone.
Hear when a new Bacterial Vaginosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.